<p>N: number of patients, IQR: interquartile range, NRTI: nucleoside reverse transcriptase inhibitor, NNRTI: non-nucleoside reverse transcriptase inhibitor.</p
<p>Data are mean (SD), median (IQR), or number of patients (%). ACR, albumin-to-creatinine ratio; AC...
<p>NNRTI: Non-nucleoside reverse transcriptase inhibitor, NRTI: Nucleoside reverse transcriptase inh...
<p>IQR, interquartile range.</p><p>*Median (IQR[range])</p><p>Patient characteristics (N = 213,945)....
<p>IQR: interquartil range; ART: antiviral therapy; PI: protease inhibitor; NRTI: nucleoside reverse...
<p>IQR, interquartile range; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, non-nucleos...
<p>M: median. N(t)RTIs: nucleos(t)ide analogue reverse transcriptase inhibitors. NNRTI: nonnucleosid...
<p><sup>†</sup>median (interquartile range)</p><p>Nine patients were taking both PI/r and NNRTI, 1 p...
<p>BMI: Body mass index; SD: Standard deviation; NNRTI: Non-nucleoside reverse transcriptase inhibit...
<p><b>NOTE:</b> Data are median (IQR -Interquartile range-). FRs: Full Responders; INRs : Immunologi...
<p>ART, antiretroviral therapy; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleo...
<p>Data are median (IQR) unless otherwise stated, IDU-intravenous drug use, Ab-antibody, SAg-surface...
<p>Baseline Characteristics of Patients According to Quartiles of Baseline NLR Level.</p
§<p>Percent or median with interquartile range.</p>*<p>Between-group p≤0.05.</p>†<p>Defined as self-...
<p>* p<0.01 calculated by χ2 test.</p><p>† p<0.01 calculated by ANOVA or two sided <i>t</i> test.</p...
<p>IQR: interquartile range. Pre-stroke independency was defined as mRS 0–1 before onset.</p><p>Base...
<p>Data are mean (SD), median (IQR), or number of patients (%). ACR, albumin-to-creatinine ratio; AC...
<p>NNRTI: Non-nucleoside reverse transcriptase inhibitor, NRTI: Nucleoside reverse transcriptase inh...
<p>IQR, interquartile range.</p><p>*Median (IQR[range])</p><p>Patient characteristics (N = 213,945)....
<p>IQR: interquartil range; ART: antiviral therapy; PI: protease inhibitor; NRTI: nucleoside reverse...
<p>IQR, interquartile range; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, non-nucleos...
<p>M: median. N(t)RTIs: nucleos(t)ide analogue reverse transcriptase inhibitors. NNRTI: nonnucleosid...
<p><sup>†</sup>median (interquartile range)</p><p>Nine patients were taking both PI/r and NNRTI, 1 p...
<p>BMI: Body mass index; SD: Standard deviation; NNRTI: Non-nucleoside reverse transcriptase inhibit...
<p><b>NOTE:</b> Data are median (IQR -Interquartile range-). FRs: Full Responders; INRs : Immunologi...
<p>ART, antiretroviral therapy; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleo...
<p>Data are median (IQR) unless otherwise stated, IDU-intravenous drug use, Ab-antibody, SAg-surface...
<p>Baseline Characteristics of Patients According to Quartiles of Baseline NLR Level.</p
§<p>Percent or median with interquartile range.</p>*<p>Between-group p≤0.05.</p>†<p>Defined as self-...
<p>* p<0.01 calculated by χ2 test.</p><p>† p<0.01 calculated by ANOVA or two sided <i>t</i> test.</p...
<p>IQR: interquartile range. Pre-stroke independency was defined as mRS 0–1 before onset.</p><p>Base...
<p>Data are mean (SD), median (IQR), or number of patients (%). ACR, albumin-to-creatinine ratio; AC...
<p>NNRTI: Non-nucleoside reverse transcriptase inhibitor, NRTI: Nucleoside reverse transcriptase inh...
<p>IQR, interquartile range.</p><p>*Median (IQR[range])</p><p>Patient characteristics (N = 213,945)....
DOI
Add to ORKG